Heart and vessel hypertrophy in hypertension: possibilities of regression.

Renata Cífková(Brigham and Women's Hospital), J Widimský(Institute for Postgraduate Medical Education), L Romanovská, P Niederle, P Frídl, J Skibová, Hana Skalická(Unknown)
PubMed
December 1, 1987
Cited by 4

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Hypertension
|Nature Reviews Disease Primers|2018|1.1k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest
|JAMA|2022|674